Literature DB >> 23738532

Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation.

Martin J Brodie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23738532      PMCID： PMC3853522          DOI： 10.1111/bcp.12176

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

Review 1.  Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.

Authors:  Stefan Beyenburg; Knut Stavem; Dieter Schmidt
Journal:  Epilepsia       Date:  2009-09-10       Impact factor: 5.864

Review 2.  Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.

Authors:  Wolfgang Löscher; Dieter Schmidt
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

Review 3.  Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis.

Authors:  Sylvain Rheims; Emilio Perucca; Michel Cucherat; Philippe Ryvlin
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

Review 4.  Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis.

Authors:  João Costa; Filipa Fareleira; Raquel Ascenção; Margarida Borges; Cristina Sampaio; António Vaz-Carneiro
Journal:  Epilepsia       Date:  2011-04-19       Impact factor: 5.864

5.  Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.

Authors:  Chiara Luoni; Francesca Bisulli; Maria Paola Canevini; Giovambattista De Sarro; Cinzia Fattore; Carlo Andrea Galimberti; Giuliana Gatti; Angela La Neve; Giancarlo Muscas; Luigi Maria Specchio; Salvatore Striano; Emilio Perucca
Journal:  Epilepsia       Date:  2011-12       Impact factor: 5.864

Review 6.  Early predictors of outcome in newly diagnosed epilepsy.

Authors:  Rajiv Mohanraj; Martin J Brodie
Journal:  Seizure       Date:  2013-04-11       Impact factor: 3.184

7.  Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Authors:  Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French
Journal:  Epilepsia       Date:  2009-11-03       Impact factor: 5.864

8.  Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.

Authors:  Deana M Gazzola; Laura J Balcer; Jacqueline A French
Journal:  Epilepsia       Date:  2007-05-23       Impact factor: 5.864

9.  Patterns of treatment response in newly diagnosed epilepsy.

Authors:  M J Brodie; S J E Barry; G A Bamagous; J D Norrie; P Kwan
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

Review 10.  Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials.

Authors:  Pritesh N Bodalia; Anthony M Grosso; Reecha Sofat; Raymond J Macallister; Liam Smeeth; Soraya Dhillon; Juan-Pablo Casas; David Wonderling; Aroon D Hingorani
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335
  10 in total
  3 in total

1.  Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Gail S Bell; Josemir W Sander
Journal:  Eur J Clin Pharmacol       Date:  2014-03-28       Impact factor: 2.953

2.  Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data.

Authors:  Alexandra Rohracher; Gudrun Kalss; Markus Leitinger; Claudia Granbichler; Ildiko Deak; Judith Dobesberger; Giorgi Kuchukhidze; Aljoscha Thomschewski; Julia Höfler; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2016-09-01       Impact factor: 6.570

Review 3.  Perampanel for focal epilepsy: insights from early clinical experience.

Authors:  E Trinka; B J Steinhoff; M Nikanorova; M J Brodie
Journal:  Acta Neurol Scand       Date:  2015-10-28       Impact factor: 3.209
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.